Cancers of the Head & Neck | Home

Cancers of the Head & Neck | Home





Cancers of the Head & Neck

Articles

• Recent
• Most accessed

Recent articles RSS

1. REVIEW

   Radiotherapy plus EGFR inhibitors: synergistic modalities

   Paolo Bossi and Francesca Platini

   Published on: 18 January 2017
2. REVIEW

   Indolent thyroid cancer: knowns and unknowns

   Lewis D. Hahn, Christian A. Kunder, Michelle M. Chen, Lisa A. Orloff and Terry S. Desser

   Published on: 11 January 2017
3. REVIEW

   De-intensification of adjuvant therapy in human papillomavirus-associated oropharyngeal cancer

   Yi An, F. Christopher Holsinger and Zain A. Husain

   Published on: 20 December 2016
4. CASE REPORT

   An unusual case of tracheo-pleural fistula and cardiac metastases in oropharyngeal carcinoma: a case report and review of the literature

   Daris Ferrari, Carla Codecà, Giulia Viale, Barbara Bocci, Francesca Broggio, Francesca Crepaldi, Martina Violati, Andrea Luciani, Dario Bauer, Laura Moneghini, Gaetano Bulfamante and Paolo Foa

   Published on: 15 December 2016
5. REVIEW

   Using 3D computer planning for complex reconstruction of mandibular defects

   Diana N. Kirke, Randall P. Owen, Vincent Carrao, Brett A Miles and Jason I. Kass

   Published on: 9 December 2016

View all articles

Call for papers: Translational oncology

We are pleased to announce that a number of BioMed Central journals have come together to create a new cross-journal series on translational oncology.

Guest Edited by Prof Tommaso Dragani (Fondazione IRCCS Istituto Nazionale dei Tumori, Italy), the series is now accepting submissions of research articles that provide important developments in cancer research. Preclinical studies should provide a significant advance in knowledge, and have clear potential for strong clinical impact.

More information

Editor's profile

Barbara Burtness, Editor-in-Chief
Barbara Burtness studied medicine at the State University of New York at Stony Brook, following graduation from Bryn Mawr College. She trained in internal medicine at Yale-New Haven Hospital and in medical oncology at Memorial-Sloan Kettering Cancer Center. She was Assistant and Associate Professor at Yale University (1993-2005), and worked at Fox Chase Cancer Center from 2005 to 2014, serving as Associate Director for Clinical Research and Section Chief of Head and Neck Oncology. She is Professor of Medicine at Yale University School of Medicine, and Co-Leader of the Developmental Therapeutics Program in the Yale Cancer Center. She is Chair of the Head and Neck Therapeutics Committee in ECOG-ACRIN. She co-edits the text Molecular Determinants of Head and Neck Cancer.

Barbara has research interests in drug development in head and neck cancer, resistance to EGFR inhibition, as well as the use of network modeling to target survival kinases in cancers with tumor suppressor gene mutation.